Skip to search formSkip to main contentSkip to account menu

oxaceprol

Known as: 1-acetyl-4-hydroxy-L- proline, N-acetyl-4-hydroxyproline, N-acetylhydroxyproline 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Oxaceprol is well‐defined therapeutic agent as an atypical inhibitor of inflammation in osteoarthritis. In the present study, we… 
2014
2014
Objectives: Osteoarthritis (OA) is the most common form of arthritis which has a growing number of patients and having major… 
2007
2007
OBJECTIVE To evaluate efficacy of therapy with oxaceprol in the treatment of symptomatic osteoarthritis of knee or hip. METHODS… 
2001
2001
Oxaceprol (N-acetyl-L-hydroxyproline), an atypical inhibitor of inflammation, is an established drug for joint disease without… 
1998
1998
Oxaceprol, an established drug for treatment of degenerative joint disease, has recently been shown in vitro to reduce leukocyte… 
1991
1991
Calf articular cartilage fragments were incubated in vitro in the absence and presence of 170 micrograms N-acethyl-trans-4… 
1990
1990
The authors have studied in organ culture, the effects of oxaceprol-structural analogue of hydroxyproline, on the proteoglycan… 
1990
1990
Blood and plasma levels and renal and faecal excretion of 14C-oxaceprol (N-acetyl-4-hydroxyproline, AHP 200) were measured after… 
1987
1987
Using the radiolabelled precursors (3H-Glucosamine, 3H-proline) and a new procedure of quantitative microautoradiography we… 
1986
1986
Les auteurs ont cherchéà mettre en évidence éventuelle action d'un lipoaminoacide, le butyrylhydroxyproline, à la fois sur la…